The new IHI project aims to deliver tools and resources to facilitate the set-up and conduct of trials for rare and ultra-rare diseases while minimising the burden for patients.
The new IHI project aims to deliver tools and resources to facilitate the set-up and conduct of trials for rare and ultra-rare diseases while minimising the burden for patients.
Discover how our projects are having a real impact on research in diverse areas.
The GRIPonMASH project aims to transform the way we detect and diagnose a common, but little-known, liver condition dubbed MASLD.
Our governance structure ensures that IHI benefits from the input of a diverse range of stakeholders.
While the incidence of Alzheimer’s disease continues to grow at an alarming rate, advances in treatment and prevention have stalled. IMI's ADAPTED project worked to better...
The algorithms that translate walking patterns into indicators of health have been integrated by private companies EMPATICA, Clario, McRoberts and Actigraph into their products.
Despite challenging conditions posed by the COVID-19 outbreak, the DRIVE project successfully tested how well various brands of flu vaccines worked across five European countries...